FRESENIUS MEDICAL CARE-ADR (FMS)

Why Dialysis Stocks DaVita, Fresenius Soared On Novo's Ozempic News

Novo Nordisk tested its diabetes and weight-loss drug in patients with chronic kidney disease.

Stock Market Whiplash

We've also got a look at the international real estate market.

AbbVie, Amgen cited in latest Medicare inflation penalties

The Biden administration identifies 48 Medicare Part B drugs subject to inflation penalties in Q1 2024. Read more here.

Only Have $100? 3 No-Brainer Stocks to Buy Right Now

The stock market is such a well-oiled, wealth-generating machine that investors can start with just $100 to buy these no-brainer stocks.

Fresenius settles litigation over Tricare program (NYSE:FMS)

Fresenius Medical Care (FMS) on Tuesday said it had entered into a final settlement with the U.S. government over the Tricare program.

Fresenius recalls Sanxin hemodialysis syringes over leakage issues (NYSE:FMS)

Fresenius Medical Care (FMS) has recalled its Sanxin single-use syringes, which are used with its 2008T hemodialysis machines, over reported leakage issues. Read more here.

Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?

Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story.

Capital Square Delivers 149.59% Total Return* to Investors in Medical Building DST

/PRNewswire/ -- Capital Square, one of the nation's leading sponsors of tax-advantaged real estate investments and an active developer and manager of...

Stock Market Rallies, Hits Resistance; Novo Nordisk, JPMorgan, Exxon In Focus: Weekly Review

The major indexes stalled at key levels amid weak breadth.

Fresenius sees GLP-1 drugs having neutral impact on its business: report (FMS)

Fresenius Medical Care said it sees GLP-1 drugs as having a neutral impact on its dialysis business, according to a report. Read more here.

Dialysis stocks decline again as Novo Nordisk hits 52-week high (DVA)

Dialysis stocks declined for the second day as Novo Nordisk shares hit a new 52-week high following an update on Novo's study on Ozempic in the treatment of kidney failure.

Why Dialysis Stocks Plunged Today

Novo Nordisk indicated one of its diabetes drugs could also be used to treat kidney disease. Here's what investors need to know.

Why Shares of Fresenius Medical Care Were Dropping on Wednesday

Positive trial news for a kidney failure drug could cut into business for dialysis therapies companies such as Fresenius.

Ozempic Is Moving a Bunch of Stocks Wednesday Morning

Find out who the winners and losers are.

Dialysis stocks tumble in wake of Ozempic kidney failure study update

Shares of DaVita, Baxter International, Fresenius Medical Care, and Outset Medical fell sharply in pre-market trading following an update on an Ozempic kidney failure study.

Capital Square Delivers 147.63% Total Return* to Investors in Medical Building DST

/PRNewswire/ -- Capital Square, one of the nation's leading sponsors of tax-advantaged real estate investments and an active developer of multifamily...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Pre-market stock movers are a hot topic on Wednesday morning and we're covering all of the latest news investors need to know about!

Oversold Conditions For Fresenius Medical Care (FMS)

Notable Two Hundred Day Moving Average Cross - FMS

Fresenius Medical Care Becomes Oversold (FMS)

Fresenius wins FDA OK for upgraded home dialysis system (NYSE:FMS)

Fresenius Medical Care (FMS) said Wednesday the FDA OK'd its VersiHD with GuideMe Software, a new interface for its VersiHD home hemodialysis system. Read more here.

Fresenius Medical Care falls after UBS downgrades on high consensus estimates (NYSE:FMS)

Fresenius Medical Care (FMS) fell ~6% Monday afternoon after UBS downgraded the dialysis and related services provider on high consensus earnings estimates.